Genmab | GEN - 债务利息支出





债务利息支出 更改 日
Agios Pharmaceuticals USD 1.18B 4.3B 2026-03
Amarin USD 3K 5K 2024-12
Amgen USD 657M 4M 2026-03
argenx SE USD 1000K 172K 2026-03
AstraZeneca USD 484M 181M 2025-12
Bayer EUR 675M 87M 2025-12
BioMarin Pharmaceutical USD 14.96M 12.18M 2026-03
Demant DKK 398M 37M 2025-12
Exelixis USD 23.4M 3.9M 2023-09
Fresenius Medical Care EUR 79M 6M 2026-03
Genmab DKK 10M 27M 2025-12
GlaxoSmithKline GBP 167M 21M 2026-03
GN Store Nord DKK 296M 42M 2025-12
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Insmed USD 20.08M 517K 2026-03
Lakefront Biotherapeutics EUR 1.72M 940K 2025-09
Lonza CHF 84M 14M 2025-06
Merck EUR 104M 17M 2026-03
Novartis USD 343M 39M 2026-03
Regeneron Pharmaceuticals USD 12.9M 700K 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 178M 203M 2026-03
UCB EUR 49M 29M 2025-12